Chon, E <br/><br/>
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.  [electronic resource] 

 -  Veterinary and comparative oncology  Sep 2012 
 - 184-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1476-5829 
<br/><br/><label>Standard No.: </label>10.1111/j.1476-5829.2011.00265.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Dog Diseases--drug therapy<br/>Dogs<br/>Drug Therapy, Combination<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Indoles--administration & dosage<br/>Male<br/>Neoplasms--drug therapy<br/>Piroxicam--administration & dosage<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--administration & dosage